Paragon Capital Management (Colorado)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $238K | Hold |
|
|||||
|
2024
Q4 | $221K | Hold |
|
|||||
|
2024
Q3 | $202K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $209K | Sell |
|
|||||
|
2023
Q1 | $254K | Sell |
|
|||||
|
2022
Q4 | $274K | Buy |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2022
Q2 | $268K | Buy |
|
|||||
|
2022
Q1 | $254K | Buy |
|
|||||
|
2021
Q4 | $216K | Buy |
|
|||||
|
2021
Q3 | $205K | Buy |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2021
Q1 | $218K | Buy |
|
|||||
|
2020
Q4 | $214K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $245K | Buy |
|
|||||
|
2018
Q2 | $219K | Buy |
|
|||||
|
2018
Q1 | $203K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $248K | Buy |
|